20
Participants
Start Date
March 18, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
Ziftomenib
Oral capsule
Cytarabine
Intravenous (IV) infusion
Fludarabine
IV infusion
RECRUITING
Sankt Anna-Kinderspital, Vienna
RECRUITING
Memorial Sloan Kettering Cancer Center - New York, New York
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
RECRUITING
Fondazione IRCCS San Gerardo dei Tintori (Ospedale San Gerardo), Monza
RECRUITING
Hospital Infantil Universitario Niño Jesús, Madrid
RECRUITING
Children's Healthcare of Atlanta, Atlanta
RECRUITING
CHU de Nantes - Hôpital Femme-Enfant-Adolescent, Nantes
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
CHU de Reims - Hôpital Robert Debré, Paris
RECRUITING
Texas Children's Hospital, Houston
RECRUITING
Children's Hospital Colorado, Aurora
RECRUITING
Children's Hospital Los Angeles, Los Angeles
RECRUITING
Seattle Children's Hospital, Seattle
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
RECRUITING
St. Jude Children's Research Hospital, Memphis
RECRUITING
SickKids - The Hospital for Sick Children, Toronto
RECRUITING
Ospedale Pediatrico Bambino Gesù, Roma
RECRUITING
Prinses Maxima Centrum Kinderoncologie, Utrecht
RECRUITING
Hospital Universitari Vall d'Hebrón, Barcelona
Collaborators (1)
Kura Oncology
UNKNOWN
PedAL BCU, LLC
OTHER